Möchten Sie immer auf dem neuesten Stand bleiben?

Company announcement – No. 18 / 2023 Total number of shares and voting rights in Zealand Pharma at April 28, 2023 Copenhagen, Denmark, April 28, 2023 – Zealand Pharma A/S (“Zealand”)...

Company announcement – No. 17 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Company announcement – No. 16 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Company announcement – No. 15 / 2023 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 Copenhagen, Denmark,...

Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq...

Company announcement – No. 14 / 2023 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES,...

Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen NOT FOR...

Company announcement – No. 12 / 2023 Total number of shares and voting rights in Zealand Pharma at March 31, 2023 Copenhagen, Denmark, March 31, 2023 – Zealand Pharma A/S (“Zealand”)...

Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5...

Company announcement – No. 10 / 2023 Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares NOT FOR RELEASE, PUBLICATION OR...